Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05108896 · ClinicalTrials.gov registry record · NA
Aspiration in Acute Respiratory Failure Survivors 2
A NA study of Dysphagia and Aspiration, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 855
- Enrollment target
- 5
- Study locations
NCT05108896: Recruiting NA study of Dysphagia and Aspiration, sponsored by University of Colorado, Denver.
NCT05108896 is a NA study of Dysphagia and Aspiration that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 855 participants, above the 148-participant average among 35 other Dysphagia trials with a reported enrollment target (478% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05108896, a NA study of Dysphagia and Aspiration, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 855 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.
Primary Outcome
Aspiration (PAS score of ≥6) on the FEES with any of the feeding consistencies. A PAS score of ≥ 6 includes patients with both silent and non-silent aspiration. Using a PAS cutoff score of ≥6 on FEES, patients will be stratified by aspiration on any of the five consistencies.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 3-Screenings Protocol
- DIAGNOSTIC_TEST FEES
- DIAGNOSTIC_TEST Tracheal Ultrasound
Study Locations (5)
Massachusetts
- Tufts Medical Center - Boston
- Boston University - Boston
California
- Stanford Univerity - Stanford
Colorado
- University of Colorado - Aurora
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 855 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
What NCT05108896 shows while recruiting
NCT05108896 is an interventional study that assigns participants to a tested intervention. The registered 855 participants enrollment target is mid-sized for trials with a published cap, above the 148-participant average among 35 other Dysphagia trials with a reported enrollment target (478% higher).
The record links to 2 conditions, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which 3-Screenings Protocol is the first listed.
NCT05108896 lists 5 locations in 4 states (Massachusetts, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT05108896 about?
NCT05108896 is a clinical study titled "Aspiration in Acute Respiratory Failure Survivors 2". The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.
What is the current status of trial NCT05108896?
This trial is currently recruiting. It is a NA study. The enrollment target is 855 participants. The study started on 2021-12-15. Estimated completion is 2025-12-15.
What conditions does trial NCT05108896 study?
This clinical trial studies the following conditions: Dysphagia, Aspiration.
What interventions are being tested in trial NCT05108896?
The interventions under investigation include: 3-Screenings Protocol (DIAGNOSTIC_TEST), FEES (DIAGNOSTIC_TEST), Tracheal Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05108896?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05108896 being conducted?
This trial has 5 study locations across California, Colorado, Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05108896's enrollment target sits among peer trials
855 2nd of 35 the highest of 35 other Dysphagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06231485 · 856 participants · NA
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
- NCT07005102 · 854 participants · Phase 2
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- NCT07290491 · 854 participants · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
- NCT06237452 · 852 participants · Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI